(Q34294333)

1 August 2017

title

Dimethyl fumarate - only an anti-psoriatic medication? (English)

1 reference

1 August 2017

3

Stefan Kippenberger

1 reference

1 August 2017

4

Roland Kaufmann

1 reference

1 August 2017

Markus Meissner

1

1 reference

1 August 2017

Eva Maria Valesky

series ordinal

2

1 reference

1 August 2017

publication date

17 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

10

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

793-801

1 reference

In vitro pharmacokinetics of anti-psoriatic fumaric acid esters

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis--a retrospective study (FUTURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Glutathione regulates susceptibility to oxidant-induced mitochondrial DNA damage in human lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethylfumarate is a potent inducer of apoptosis in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Inhibition of dendritic cell differentiation by fumaric acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Multiple sclerosis: a practical overview for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Detoxication enzyme inducers modify cytokine production in rat mixed glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Noninfectious granulomatous diseases: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Clearance of necrobiosis lipoidica with fumaric acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Disseminated granuloma annulare--treatment with fumaric acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Treatment of disseminated granuloma annulare with low-dose fumaric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Granuloma annulare disseminatum: successful therapy with fumaric acid ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Cutaneous sarcoidosis: updates in the pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Successful treatment of skin and lung sarcoidosis with fumaric acid ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Transient alteration of cellular redox buffering before irradiation triggers apoptosis in head and neck carcinoma stem and non-stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethylfumarate impairs melanoma growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

DMF inhibits PDGF-BB induced airway smooth muscle cell proliferation through induction of heme-oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

Dimethylfumarate inhibits NF-{kappa}B function at multiple levels to limit airway smooth muscle cell cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2012.07996.X

10.1111/J.1610-0387.2012.07996_SUPPL.X

21 January 2018

Identifiers

DOI

language of work or name

German

1 reference

10.1111/J.1610-0387.2012.07996.X

1 August 2017

language of work or name

English

0 references

1 reference